Prolonged symptoms following acute COVID-19 in adults — Diagnosis and management

Rapid response method - Posted on Feb 12 2021 - Updated on Mar 21 2024
mceclip0 - 2021-02-12 11h58m10s mceclip1 - 2021-02-12 11h58m18s mceclip2 - 2021-02-12 11h58m22s mceclip4 - 2021-02-12 11h58m33s mceclip9 - 2021-02-12 11h58m59s mceclip8 - 2021-02-12 11h58m55s mceclip3 - 2021-02-12 11h58m28s mceclip5 - 2021-02-12 11h58m37s
LOGO SFORL LOGO CMK LOGO Sofmer LOGO SFETD LOGO CNPP-CNQSP mceclip6 - 2021-02-12 11h58m43s mceclip10 - 2021-02-12 11h59m03s mceclip11 - 2021-02-12 11h59m07s Logo tous partenaires covid 

 

Recent developments

Risk factors for the onset of prolonged symptoms following acute COVID-19 have been identified: hospitalisation and high number of symptoms during the initial episode.

New symptoms have been described, such as digestive tract, skin, and eye-related symptoms. They are discussed in new toolkit guides.

Prolonged symptoms following acute COVID-19 can affect adolescents and, in rarer cases, children (a specific toolkit guide will be formulated).

WHO has proposed a definition of “post-COVID condition”. This definition is liable to change over time. It defines this condition particularly via the presence of symptoms beyond 3 months after the acute episode.

The scope of this rapid response is not confined to this definition, but provides guidance on earlier management of persistent symptoms (beyond 4 weeks), in order to rule out any differential diagnoses, including some emergency scenarios, as soon as possible, and initiate treatments and/or rehabilitation.

 

Key points

  • Rapid response No. 1: prolonged symptoms following acute COVID-19 can occur even in people who have had mild forms. These symptoms take on a variety of forms (or are polymorphic), and can fluctuate over several weeks or months.

  • Rapid response No. 2: the majority of patients can be followed up in a primary care setting using a holistic management approach.

  • Rapid response No. 3: the most commonly encountered symptoms are potentially severe fatigue, neurological problems (cognitive, sensory, headaches), cardiothoracic problems (chest pain and tightness, tachycardia, dyspnoea, cough), and smell and taste problems. Pain, digestive and skin problems are also common.

  • Rapid response No. 4: when a patient presents with prolonged symptoms following acute COVID-19, it is first of all necessary to rule out any acute phase complications, comorbidity decompensation, and any cause other than COVID-19.

  • Rapid response No. 5: a detailed clinical assessment (including a considerate collection of information, screening for orthostatic hypotension, and SpO2 measurement) can use scales and a careful paraclinical assessment. This detailed assessment is necessary to make a diagnosis in relation to these long-term symptoms. PET scans may be necessary, following neurological specialised advice or memory consultation, as part of the differential diagnosis workup.

  • Rapid response No. 6: empathetic listening and viewing the patient as a whole are important — the Primary Care Physical is central to the process. The diagnostic and care pathway must be personalised, using a patient-focused approach and support the patient. Patients should encouraged to learn self-management techniques, to know their limits, but to continue to be physically active, even to a moderate degree, while keeping within their capabilities and if there are no contraindications.

  • Rapid response No. 7: current treatments are essentially symptomatic.

  • Rapid response No. 8: rehabilitation has a central role and must account for the possibility of hyperventilation syndrome and post-exertional worsening of symptoms; olfactory rehabilitation for cases of persistent smell problems; exercise therapy after ruling out contraindications with psychological support if needed.

  • Rapid response No. 9: exploring anxiety and depression disorders, and offering psychological support and treatment tailored to the individual should be considered at all stages of the follow-up process.

  • Rapid response No. 10: scope for referral should be available within multidisciplinary and multi-professional structures, on a local level. Certain patients should be able to access multidisciplinary physiotherapy, rehabilitation, and support services.

  • Rapid response No. 11: despite the lack of follow-up to date, observed outcomes involve alternating phases of flare-up and recovery. Patient outcomes generally improve at a variable pace depending on the patients.

  • Rapid response No. 12: many scientific questions remain as to the epidemiological, physiopathological and therapeutic aspects. They must be the subject of funded research projects.

This document is made up of two parts:

  • Primary care strategies
  • Toolkit guides by symptom or specialism:
    • Autonomic Dysfunction Symptoms Toolkit Guide
    • Chest Pains Toolkit Guide
    • Digestive Tract Symptoms Toolkit Guide
    • Dyspnoea Toolkit Guide
    • Eye Disorders Toolkit Guide
    • Fatigue Toolkit Guide
    • Functional Somatic Disorders Toolkit Guide
    • Neurological Signs Toolkit Guide(updated)
    • Physiotherapy Toolkit Guide - exercise therapy
    • Physiotherapy Toolkit Guide - hyperventilation syndrome
    • Skin Lesions Toolkit Guide
    • Taste and Smell Problems Toolkit Guide

 

Context

This rapid response follows a referral by the French Minister of Health dated 14 December 2020 requesting that the French National Authority for Health draft, based on a multidisciplinary approach, procedures to follow, aimed at healthcare professionals, and essentially those involved in primary care, for the management and referral of patients presenting with prolonged symptoms following acute COVID-19.

COVID-19 is a disease expressed in varied forms, in terms of clinical presentation, as well as severity and duration.

From the end of the first wave of the epidemic in May 2020, symptoms persisting several weeks or months after symptom onset were reported in over 20% of patients after 5 weeks or longer, and in over 10% of patients after 3 months.[1]

To date, hospitalisation and a large number of symptoms during the initial episode have been identified as risk factors for prolonged symptoms.

The polysymptomatic and fluctuating nature of these clinical signs has given rise to questions and concerns for patients and clinicians.

COVID outcome data are still rare and the physiopathological mechanisms are hypothetical at this stage. The term “Long Covid” has been created and used by patients and adopted in the literature to describe this phenomenon. Given the lack of accurate physiopathological and epidemiological data, this document uses the broader concept of prolonged symptoms following acute COVID-19.

Pragmatic, rational and scientific management of these patients, as part of a potentially multidisciplinary approach, with a shared medical decision, is needed.

These symptoms can be managed in a primary care setting in the large majority of cases. Additional investigations may be required. 

Escalation of irrelevant investigations should be avoided.

The purpose of this document is to define the primary care of adult patients presenting with long-term symptoms. The associated toolkit guides give information on the clinical and paraclinical investigations required in a primary care setting based on organ involvement and/or the symptoms presented. They identify emergency situations and situations where specialist referral is needed.

These rapid responses have been drafted on the basis of available knowledge on the date of publication. They are liable to evolve on the basis of new data.

 

 

[1] Office for National Statistics. The prevalence of long COVID symptoms and Covid-19 complications: ONS; 2020.

https://www.ons.gov.uk/news/statementsandletters/theprevalenceoflongcovidsymptomsandcovid19complications

Contact Us

Service des bonnes pratiques
All our publications